サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1567871

欧州の上流バイオプロセス：2030年までの市場予測 - 地域分析 - 製品タイプ、ワークフロー、用途、モード別

Europe Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode

出版日
ページ情報
英文 124 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州の上流バイオプロセス：2030年までの市場予測 - 地域分析 - 製品タイプ、ワークフロー、用途、モード別
出版日: 2024年08月07日
発行: The Insight Partners
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の上流バイオプロセス市場は、2022年に25億8,159万米ドルと評価され、2030年には70億6,978万米ドルに達すると予測され、2022年から2030年までのCAGRは13.4%と推定されます。

バイオ医薬品製造のアウトソーシングが欧州の上流バイオプロセス市場を牽引

多数の開発・製造受託機関（CDMO）や製造受託機関（CMO）がバイオプロセス活動を行っており、これらの施設におけるバイオリアクターの需要を引き起こしています。バイオプロセスによる医薬品製造の戦略的アウトソーシングにより、バイオ医薬品企業は上流工程における外部パートナーの専門知識と高度な能力を活用することができ、専門技術、工程最適化の専門知識、拡張可能な製造能力へのアクセスが容易になります。CDMOやCMOと提携することで、バイオ医薬品企業は製造ニーズを効率的に管理し、生産需要の変動に対応し、中核となる研究開発に集中することができます。さらに、アウトソーシングは、外部パートナーの確立されたインフラと規制に準拠した施設を活用することで、コスト効率とリスク軽減を提供します。バイオ製薬企業は、バイオプロセス機能をアウトソーシングすることで、技術革新の促進、技術の進歩、上流工程全体の拡大に集中することができます。このように、バイオ医薬品製造のアウトソーシングは、上流バイオプロセス市場の成長を大きく後押ししています。

欧州の上流バイオプロセス市場の概要

欧州の上流バイオプロセス市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。生物製剤や医薬品の研究に政府や民間から資金が提供され、革新的な技術の発表につながっていることから、堅調な成長率が見込まれています。この地域には、会議やその他のイベントを通じて製薬業界で行われている実務を監視する様々な組織や団体があります。欧州の企業は、顧客基盤を強化し、同地域の他のプレーヤーの開発に関する情報を収集できるよう、様々なイベントで自社製品を展示することに注力しています。このように、研究イニシアティブ、革新的な製品、会議などのイベントは、欧州の上流バイオプロセス市場に利益をもたらしています。

欧州の上流バイオプロセス市場の収益と2030年までの予測（金額）

欧州の上流バイオプロセス市場のセグメンテーション

欧州の上流バイオプロセス市場は、製品タイプ、ワークフロー、用途、モード、国別に区分されます。製品タイプ別では、欧州の上流バイオプロセス市場はバイオリアクター/発酵槽、細胞培養、フィルター、バッグ・容器、その他に区分されます。バイオリアクター/発酵槽サービスは2022年に最大の市場シェアを占めました。

ワークフロー別では、欧州の上流バイオプロセス市場は培地調製、細胞培養、細胞分離に分類されます。細胞分離は2022年に最大の市場シェアを占めました。

用途別では、欧州の上流バイオプロセス市場はシングルユースとマルチユースに二分されます。2022年の市場シェアはシングルユースが大きいです。

モード別では、欧州の上流バイオプロセス市場はインハウスとアウトソーシングに二分されます。2022年の市場シェアはインハウスが大きいです。

国別では、欧州の上流バイオプロセス市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の上流バイオプロセス市場シェアはドイツが独占。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Cellexus International Ltd、Sartorius AG、Getinge AB、Merck KGaA、Corning Inc、Entegris Incは、欧州の上流バイオプロセス市場で事業展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州上流バイオプロセス市場情勢

  • PEST分析

第5章 欧州の上流バイオプロセス市場：主要市場力学

  • 市場促進要因
    • シングルユースバイオリアクターの商業利用
    • バイオ医薬品製造のアウトソーシング
    • 製薬・バイオ産業の急成長
  • 市場抑制要因
    • 厳しい規制枠組み
  • 市場機会
    • 技術の進歩
  • 今後の動向
    • バイオ医薬品業界における研究開発投資の増加
  • 促進要因と抑制要因の影響

第6章 上流バイオプロセス市場：欧州分析

第7章 欧州の上流バイオプロセス市場分析：製品タイプ別

  • バイオリアクター/発酵槽
  • 細胞培養
  • フィルター
  • バッグと容器
  • その他

第8章 欧州上流バイオプロセス市場分析：ワークフロー別

  • 培地調製
  • 細胞培養
  • 細胞分離

第9章 欧州の上流バイオプロセス市場分析：用途別

  • シングルユース
  • マルチユース

第10章 欧州の上流バイオプロセス市場分析：モード別

  • インハウス
  • アウトソース

第11章 欧州の上流バイオプロセス市場：国別分析

  • 欧州市場概要
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第12章 業界情勢

  • 上流バイオプロセス市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Cellexus International Ltd
  • Sartorius AG
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc

第14章 付録

図表

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 7. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 8. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 9. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 10. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 11. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 12. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 13. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 14. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 15. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 16. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 17. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 18. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 19. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 20. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 21. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 22. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 23. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 24. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 25. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 26. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 27. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 28. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 30. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 31. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 32. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 33. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Europe Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Europe: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Upstream Bioprocessing Market
目次
Product Code: BMIRE00030684

The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030.

Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market

A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market.

Europe Upstream Bioprocessing Market Overview

The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe.

Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Europe Upstream Bioprocessing Market Segmentation

The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Europe Analysis

7. Europe Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Upstream Bioprocessing Market - Country Analysis

  • 11.1 Europe Market Overview
    • 11.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 UK
      • 11.1.1.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Germany
      • 11.1.1.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 France
      • 11.1.1.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.8 Italy
      • 11.1.1.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.10 Spain
      • 11.1.1.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.12 Rest of Europe
      • 11.1.1.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Cellexus International Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms